Ionis Pharmaceuticals, Inc.
Methods and compositions for inhibiting PMP22 expression
Last updated:
Abstract:
The present embodiments provide methods, compounds, and compositions useful for inhibiting PMP22 expression and for treating, preventing, or ameliorating a disease associated with PMP22.
Status:
Grant
Type:
Utility
Filling date:
9 Mar 2017
Issue date:
5 Oct 2021